N@N

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $80 on, Nov 9th, 2022

Graig Suvannavejh of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $76 to $80 on, Nov 9th, 2022.

Graig has made no other calls on AXSM in the last 4 months.

There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $73 on, Tuesday, November 8th, 2022

These are the ratings of the 5 analyists that currently disagree with Graig

---

• Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
• Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $72 on, Friday, October 14th, 2022
• Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
• Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
• Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022

Contributing Sources

---